Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Allergy Therapeutics plc    AGY   GB00B02LCQ05

ALLERGY THERAPEUTICS PLC

(AGY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Allergy Therapeutics plc
Allergy Therapeutics Plc is a pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum-free products. The Company's segments are Central Europe, which includes segments, such as Germany, Australia, Switzerland and the Netherlands; Southern Europe, which includes Italy and Spain; the United Kingdom, and Rest of World. The Company provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's products include Pollinex Trees, Pollinex Grasses+Rye, Skin Prick Testing and diagnostic products. Its vaccines trade under various brand names, such as Pollinex Quattro, Polligoid and TA Graser Top. It uses specialized systems to process the Tyrosine to form a suspension microcrystalline tyrosine (MCT) that is combined with some of its subcutaneous injected therapies.
Sales per Business
20192020Delta
GBP (in Million)%GBP (in Million)%
Pharmaceutical Products73.72100%78.20100% +6.09%
Sales per region
2020
GBP (in Million)%
Germany47.9861.3%
Other Central Europe12.2715.7%
Spain7.9410.2%
Rest of World (including United Kingdom)4.836.2%
Italy4.495.7%
Other Southern Europe0.6900.9%
Managers
NameAgeSinceTitle
Manuel Llobet542012Chief Executive Officer & Executive Director
Peter Sinclair Jensen692011Non-Executive Chairman
Bev Lees-1998Group Director-Operations
Nicolas Alexander Ulrich Wykeman54-Chief Financial Officer & Executive Director
Murray Skinner, Dr.-2004Chief Scientific Officer
Stephen Rushworth Smith662012Senior Independent Non-Executive Director
Babatunde Adekunle Otulana, Dr.622017Non-Executive Director
Scott Leinenweber-2018Non-Executive Director
Mary Geraldine Tavener572019Non-Executive Director
Sara Goldsbrough-2016Secretary
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 639,863,727 102,215,159 16.0% 0 0.0% 16.0%
Stock B 0 9,848,333 0 0.0% 0 0.0%
Shareholders
NameEquities%
Abbott Laboratories 240,584,571 37.6%
Southern Fox Investments Ltd. 143,690,342 22.5%
Skygem Acquisition Ltd. 128,622,798 20.1%
Invesco Asset Management Ltd. 30,350,000 4.74%
BlackRock Investment Management (UK) Ltd. 30,350,000 4.74%
River & Mercantile Asset Management LLP 20,457,086 3.20%
JPMorgan Investment Management, Inc. 14,857,000 2.32%
Hargreaves Lansdown Stockbrokers Ltd. 11,765,000 1.84%
Miton Asset Management Ltd. 10,716,292 1.67%
GlaxoSmithKline plc 10,118,000 1.58%
Company contact information
Allergy Therapeutics Plc
Dominion Way
Worthing, West Sussex BN14 8SA

Phone : +44.1903.844.700
Fax : +44.1903.844.726
Web : http://allergytherapeutics.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ALLERGY THERAPEUTICS PLC51.22%132
JOHNSON & JOHNSON-0.82%380 876
ROCHE HOLDING AG-4.76%282 467
PFIZER, INC.3.21%212 942
NOVARTIS AG-10.48%206 479
MERCK & CO., INC.-11.61%203 389
ABBVIE INC.18.12%184 633
NOVO NORDISK A/S8.55%155 951
BRISTOL-MYERS SQUIBB COMPANY-2.79%141 008
ASTRAZENECA PLC2.60%136 635
ELI LILLY AND COMPANY10.82%132 044
AMGEN INC.-7.89%129 265
SANOFI-5.48%127 199
GLAXOSMITHKLINE PLC-22.99%90 971
CHUGAI PHARMACEUTICAL CO., LTD.50.12%79 458
JIANGSU HENGRUI MEDICINE CO., LTD.17.90%69 083
DAIICHI SANKYO COMPANY, LIMITED53.32%68 872
BAYER AG-33.70%56 677
TAKEDA PHARMACEUTICAL COMPANY LIMITED-13.55%56 107
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED43.82%28 440
ASTELLAS PHARMA INC.-20.67%26 407